Back

Corrigendum to: Sodium-glucose cotransporter 2 inhibitors in patients with heart failure: a systematic review and meta-analysis of randomized trials

European Heart Journal - Quality of Care and Clinical Outcomes

15 February 2022
Organised by: Logo
Read full article
ESC Journals
You may be interested in
thumbnail
Congress Presentation
Efficacy of sodium-glucose cotransporter-2 inhibitors in heart failure patients treated with dual angiotensin receptor blocker-neprilysin inhibitor: an updated meta-analysis.
29 June 2021
thumbnail
Congress Session
Diabetes, obesity, and heart failure
19 May 2025
thumbnail
Congress Presentation
Sodium–glucose cotransporter-2 inhibitors as adjunctive therapy in left ventricular assist device recipients without diabetes: a real-world cohort study
30 August 2026
thumbnail
Congress Session
Editor's Choice: report from the heart failure sections of ESC Journal Family and overview of the ESC Textbook of Heart Failure
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources